TABLE 4.
Assay | Sample vol (ml) | Quantitative limita
|
% of RNA values above upper limit of detectionb | No. of samples/run | Maximun no. of reportable resultsc | Ease of execution | Costs of disposable items/reportable result (timesd) | |
---|---|---|---|---|---|---|---|---|
Upper | Lower | |||||||
usCA MONITOR 1.5 | 0.5 | 75,000 | 50 | 16.9 | 12 | 30 | Moderate | 3.8 |
NucliSens | 0.01–2.0 | 8,000,000 | 80 | 0.3 | 10 | 30 | Less moderatee | 4.5 |
bDNA 3.0 | 1.0 | 500,000 | 50 | 0.9 | 96 | 84 | Moderate | 1 |
Copies per milliliter for usCA MONITOR 1.5 and bDNA 3.0; copies per input for NucliSens.
According to RNA levels obtained for 19,347 specimens tested between 1 April 1999 and 31 March 2000 in the Canadian province of Quebec.
Per day for usCA MONITOR 1.5 and NucliSens and per 1.5 days for bDNA 3.0.
Relative to bDNA 3.0.
The detection procedure is the labor-intensive phase, as it necessitates numerous pipetting steps.